多发性-话题@MedSci

#多发性#

905篇内容 | 2959人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890186, encodeId=8418189018679, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=FDA暂停CAR-T疗法UCARTCS1治疗多发性骨髓瘤的临床试验, objectType=article, longId=203554, objectId=dd3d2035543d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd3d2035543d, replyNumber=0, likeNumber=0, createdTime=2021-02-27, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd3d2035543d, moduleTitle=FDA暂停CAR-T疗法UCARTCS1治疗多发性骨髓瘤的临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd3d2035543d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890252, encodeId=0d9f1890252cd, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：自体造血干细胞移植，可有效改善多发性硬化预后, objectType=article, longId=211734, objectId=1686211e3437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1686211e3437, replyNumber=0, likeNumber=95, createdTime=2022-02-26, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1686211e3437, moduleTitle=Neurology：自体造血干细胞移植，可有效改善多发性硬化预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1686211e3437)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890187, encodeId=6620189018e92, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Lancet Neurol：金刚烷胺、莫达非尼和哌醋甲酯对多发性硬化性疲劳效果不显著, objectType=article, longId=203710, objectId=1345203e10cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1345203e10cf, replyNumber=0, likeNumber=76, createdTime=2021-06-01, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1345203e10cf, moduleTitle=Lancet Neurol：金刚烷胺、莫达非尼和哌醋甲酯对多发性硬化性疲劳效果不显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1345203e10cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890235, encodeId=fdfd189023548, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Cell Death Differ：NDP52突变能够促进线粒体自噬并抑制多发性硬化症中的炎症反应, objectType=article, longId=209134, objectId=c5ec20913415, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5ec20913415, replyNumber=0, likeNumber=87, createdTime=2021-11-19, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5ec20913415, moduleTitle=Cell Death Differ：NDP52突变能够促进线粒体自噬并抑制多发性硬化症中的炎症反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5ec20913415)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890229, encodeId=2d661890229ad, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=AACR 2021：抗CD47抗体AO-176治疗实体瘤和多发性骨髓瘤，临床前试验取得积极结果, objectType=article, longId=208262, objectId=b4f5208262d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4f5208262d5, replyNumber=0, likeNumber=83, createdTime=2021-06-27, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4f5208262d5, moduleTitle=AACR 2021：抗CD47抗体AO-176治疗实体瘤和多发性骨髓瘤，临床前试验取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4f5208262d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890216, encodeId=4d481890216cc, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=J Clin Oncol：以达雷木单抗联合疗法治疗多发性骨髓瘤的持续性MRD阴性情况（POLLUX和CASTOR）, objectType=article, longId=206596, objectId=62c62065968a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62c62065968a, replyNumber=0, likeNumber=81, createdTime=2021-08-20, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62c62065968a, moduleTitle=J Clin Oncol：以达雷木单抗联合疗法治疗多发性骨髓瘤的持续性MRD阴性情况（POLLUX和CASTOR）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62c62065968a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890197, encodeId=87db189019e20, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Lancet oncol：帕比司他联合皮下给予硼替佐米治疗复发性/难治性多发性骨髓瘤的疗效和安全性, objectType=article, longId=204420, objectId=fbc5204420da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbc5204420da, replyNumber=0, likeNumber=66, createdTime=2021-04-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbc5204420da, moduleTitle=Lancet oncol：帕比司他联合皮下给予硼替佐米治疗复发性/难治性多发性骨髓瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbc5204420da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890213, encodeId=5f14189021375, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology:30万人研究揭示，多发性硬化患者的癌症发病和死亡率, objectType=article, longId=206343, objectId=9d0c20634378, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d0c20634378, replyNumber=0, likeNumber=108, createdTime=2021-10-25, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d0c20634378, moduleTitle=Neurology:30万人研究揭示，多发性硬化患者的癌症发病和死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d0c20634378)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890238, encodeId=65691890238fd, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=CD38抑制剂Sarclisa/卡非佐米/地塞米松（Kd）治疗晚期多发性骨髓瘤，已获FDA批准, objectType=article, longId=209632, objectId=570b20963284, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=570b20963284, replyNumber=0, likeNumber=75, createdTime=2021-10-06, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=570b20963284, moduleTitle=CD38抑制剂Sarclisa/卡非佐米/地塞米松（Kd）治疗晚期多发性骨髓瘤，已获FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=570b20963284)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890260, encodeId=f45e1890260de, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=BMJ:关于采用DMT治疗的多发性硬化患者接种COVID-19 mRNA疫苗的争论, objectType=article, longId=212205, objectId=55fd212205a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55fd212205a6, replyNumber=0, likeNumber=77, createdTime=2021-12-28, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55fd212205a6, moduleTitle=BMJ:关于采用DMT治疗的多发性硬化患者接种COVID-19 mRNA疫苗的争论, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55fd212205a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890262, encodeId=a59118902622f, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：多发性骨髓瘤老年患者Rd诱导化疗后可单采用低剂量来那度胺维持治疗, objectType=article, longId=212562, objectId=61ab21256220, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61ab21256220, replyNumber=0, likeNumber=102, createdTime=2021-10-20, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61ab21256220, moduleTitle=Blood：多发性骨髓瘤老年患者Rd诱导化疗后可单采用低剂量来那度胺维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61ab21256220)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890249, encodeId=416d18902497a, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=NEJM：抗B细胞成熟抗原CAR-T细胞疗法bb2121治疗多发性骨髓瘤的效果, objectType=article, longId=211106, objectId=51f721110637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51f721110637, replyNumber=0, likeNumber=82, createdTime=2021-08-17, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51f721110637, moduleTitle=NEJM：抗B细胞成熟抗原CAR-T细胞疗法bb2121治疗多发性骨髓瘤的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51f721110637)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890160, encodeId=3f60189016026, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP：慢性炎症性脱髓鞘性多发性神经根病中糖尿病和其他并发症的发生频率及其对临床表现和治疗反应的影响, objectType=article, longId=200594, objectId=ca4320059446, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca4320059446, replyNumber=0, likeNumber=82, createdTime=2021-01-30, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca4320059446, moduleTitle=JNNP：慢性炎症性脱髓鞘性多发性神经根病中糖尿病和其他并发症的发生频率及其对临床表现和治疗反应的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca4320059446)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890185, encodeId=514a1890185ff, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Clin Cancer Res：多发性骨髓瘤 | 来那度胺的“大剂量”累觉不爱, objectType=article, longId=203511, objectId=954920351191, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=954920351191, replyNumber=0, likeNumber=73, createdTime=2021-01-30, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=954920351191, moduleTitle=Clin Cancer Res：多发性骨髓瘤 | 来那度胺的“大剂量”累觉不爱, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=954920351191)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890155, encodeId=461a18901557f, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=NATURE：肠道微生物可以加剧多发性硬化症, objectType=article, longId=199966, objectId=f6d81999664a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6d81999664a, replyNumber=0, likeNumber=82, createdTime=2020-12-27, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6d81999664a, moduleTitle=NATURE：肠道微生物可以加剧多发性硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6d81999664a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890194, encodeId=184d1890194de, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=ASH 2020：亘喜生物BCMA/CD19双靶向CAR-T治疗复发或难治多发性骨髓瘤首次人体治疗数据惊艳, objectType=article, longId=204260, objectId=d025204260e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d025204260e3, replyNumber=0, likeNumber=74, createdTime=2021-11-12, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d025204260e3, moduleTitle=ASH 2020：亘喜生物BCMA/CD19双靶向CAR-T治疗复发或难治多发性骨髓瘤首次人体治疗数据惊艳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d025204260e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890166, encodeId=723e189016652, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Diabetes Care：2型糖尿病患者他汀类药物治疗与多发性神经病风险的关系, objectType=article, longId=201582, objectId=4eca201582b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eca201582b6, replyNumber=0, likeNumber=65, createdTime=2021-02-20, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eca201582b6, moduleTitle=Diabetes Care：2型糖尿病患者他汀类药物治疗与多发性神经病风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4eca201582b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890208, encodeId=65de189020886, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Lancet Haematol：来那度胺-硼替佐米-地塞米松±Elotuzumab治疗高危型多发性骨髓瘤, objectType=article, longId=206006, objectId=dea22060068e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dea22060068e, replyNumber=0, likeNumber=65, createdTime=2021-07-05, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dea22060068e, moduleTitle=Lancet Haematol：来那度胺-硼替佐米-地塞米松±Elotuzumab治疗高危型多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dea22060068e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890170, encodeId=54d418901e0a2, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=英国NICE积极推荐将赛诺菲的CD38单抗Sarclisa，用于治疗复发/难治性多发性骨髓瘤, objectType=article, longId=202215, objectId=ec9a2022152a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec9a2022152a, replyNumber=0, likeNumber=67, createdTime=2020-12-23, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec9a2022152a, moduleTitle=英国NICE积极推荐将赛诺菲的CD38单抗Sarclisa，用于治疗复发/难治性多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec9a2022152a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890245, encodeId=b7041890245a8, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle= Nat Neurosci.：多发性硬化治疗新方向：小胶质细胞可以清除多发性硬化症中的有毒脂质, objectType=article, longId=210576, objectId=42482105e6ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42482105e6ee, replyNumber=0, likeNumber=90, createdTime=2022-01-20, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42482105e6ee, moduleTitle= Nat Neurosci.：多发性硬化治疗新方向：小胶质细胞可以清除多发性硬化症中的有毒脂质, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42482105e6ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

多发性

2020-05-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

FDA暂停CAR-T疗法UCARTCS1治疗多发性骨髓瘤的临床试验

2021-02-27

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：自体造血干细胞移植，可有效改善多发性硬化预后

2022-02-26

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Lancet Neurol：金刚烷胺、莫达非尼和哌醋甲酯对多发性硬化性疲劳效果不显著

2021-06-01

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Cell Death Differ：NDP52突变能够促进线粒体自噬并抑制多发性硬化症中的炎症反应

2021-11-19

jml2009 (审核中...)

前往app查看评论内容

#多发性#

AACR 2021：抗CD47抗体AO-176治疗实体瘤和多发性骨髓瘤，临床前试验取得积极结果

2021-06-27

jml2009 (审核中...)

前往app查看评论内容

#多发性#

J Clin Oncol：以达雷木单抗联合疗法治疗多发性骨髓瘤的持续性MRD阴性情况（POLLUX和CASTOR）

2021-08-20

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Lancet oncol：帕比司他联合皮下给予硼替佐米治疗复发性/难治性多发性骨髓瘤的疗效和安全性

2021-04-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology:30万人研究揭示，多发性硬化患者的癌症发病和死亡率

2021-10-25

jml2009 (审核中...)

前往app查看评论内容

#多发性#

CD38抑制剂Sarclisa/卡非佐米/地塞米松（Kd）治疗晚期多发性骨髓瘤，已获FDA批准

2021-10-06

jml2009 (审核中...)

前往app查看评论内容

#多发性#

BMJ:关于采用DMT治疗的多发性硬化患者接种COVID-19 mRNA疫苗的争论

2021-12-28

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：多发性骨髓瘤老年患者Rd诱导化疗后可单采用低剂量来那度胺维持治疗

2021-10-20

jml2009 (审核中...)

前往app查看评论内容

#多发性#

NEJM：抗B细胞成熟抗原CAR-T细胞疗法bb2121治疗多发性骨髓瘤的效果

2021-08-17

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP：慢性炎症性脱髓鞘性多发性神经根病中糖尿病和其他并发症的发生频率及其对临床表现和治疗反应的影响

2021-01-30

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Clin Cancer Res：多发性骨髓瘤 | 来那度胺的“大剂量”累觉不爱

2021-01-30

jml2009 (审核中...)

前往app查看评论内容

#多发性#

NATURE：肠道微生物可以加剧多发性硬化症

2020-12-27

jml2009 (审核中...)

前往app查看评论内容

#多发性#

ASH 2020：亘喜生物BCMA/CD19双靶向CAR-T治疗复发或难治多发性骨髓瘤首次人体治疗数据惊艳

2021-11-12

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Diabetes Care：2型糖尿病患者他汀类药物治疗与多发性神经病风险的关系

2021-02-20

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Lancet Haematol：来那度胺-硼替佐米-地塞米松±Elotuzumab治疗高危型多发性骨髓瘤

2021-07-05

jml2009 (审核中...)

前往app查看评论内容

#多发性#

英国NICE积极推荐将赛诺菲的CD38单抗Sarclisa，用于治疗复发/难治性多发性骨髓瘤

2020-12-23

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Nat Neurosci.：多发性硬化治疗新方向：小胶质细胞可以清除多发性硬化症中的有毒脂质

2022-01-20

科室
- - 订阅+
  - 更多科室
工具
服务